Dr. Matt Kalaycio’s top 10 hematologic oncology abstracts for ASCO 2016May 27, 2016CMLAMLCLLT Cell Lymphomas
Rigosertib falls short for high-risk myelodysplastic syndromes after failure on azacitidine or decitabineApril 13, 2016Myelodysplastic SyndromeAML
Rigosertib falls short for high-risk myelodysplastic syndromes after failure on azacitidine or decitabineApril 13, 2016Myelodysplastic SyndromeAML
In myelodysplastic syndrome, improved tool for predicting death after HCTApril 11, 2016Myelodysplastic SyndromeAMLCellular Therapy
Colombia reports first Zika deaths, all in medically compromised patientsApril 10, 2016AMLAnemiaBleeding Disorders
Drug for conditioning AML patients for transplant gets orphan drug designationMarch 31, 2016AMLCellular Therapy
Nanoparticles deliver Aurora kinase inhibitor with increased safety and efficacyFebruary 12, 2016AMLTranslational Research
